DobeCure
Business Services · Spain · 1-10 Employees
View Company Info for Free
Overview
Headquarters
C/ San Emilio 6 local 1, Madrid, Madrid,...Phone Number
+34 691494049Website
www.dobecure.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About DobeCure
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is DobeCure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at DobeCure
Website visits: Recent activity has been detected on your website
DobeCure, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if DobeCure had a recent Job posting/layoffs
Check out if DobeCure is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when DobeCure launches new products
Funding: Get notified immidiatlly once DobeCure has new funding data
Check if DobeCure has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on DobeCure recently announced quarterly report
Recommended Actions
Find VP level buyers at DobeCure
Find more new buyers
Company Profile Activity
Activity Insights
DobeCure is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
DobeCure is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about DobeCure.
DobeCure Tech Stack
A closer look at the technologies used by DobeCure
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DobeCure
Dobecure is a biomedical investigation company based in Madrid, Spain, focused on developing therapies using synthetic inhibitors of fibroblast growth factor (FGF) for diseases related to inflammation and angiogenesis. Their research primarily targets ophthalmology diseases such as age-related macular degeneration, uveitis, corneal edema, and herpe... Read More
